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Abstract Gastric ulcer is a very common gastrointestinal disorder affecting a large number of people worldwide. It arises
due to an imbalance between aggressive (acid, pepsin and Helicobacter pylori infection) and protective (mucin secretion,
prostaglandin, epidermal growth factors and bicarbonate) factors in the stomach. In this study, the gastroprotective activity
has been investigated of the active constituents from Xylocarpus molluccensis. Antiulcer activity of xyloccensins X?Y was
investigated and found to be active in various ulcer models in Sprague–Dawley (SD) rats. To understand the mechanism of
action of active constituent of natural products, the effects of the compounds on antisecretory and cytoprotective activities
were studied. Air dried fruits were extracted with ethanol and fractionated into four fractions. Xyloccensins X?Y were
isolated from the active fraction and was tested against different ulcer models. Xyloccensins X?Y were found to possess
anti-ulcerogenic activity. The antiulcer activity might be due to its anti-secretory activity and subsequent strengthening of
the defensive mechanism. The present study has helped us in identifying a new lead in the form of xyloccensins that could
be exploited in the treatment of gastric ulcer disease.
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1 Introduction
Gastric ulcer is a very common gastrointestinal disorder
affecting a large number of people worldwide. It arises due
to an imbalance between aggressive (acid, pepsin and
Helicobacter pylori infection) and protective (mucin
secretion, prostaglandin, epidermal growth factors and
bicarbonate) factors in the stomach [1]. Stress, smoking,
alcohol consumption, H. pylori infection and excessive use
of non-steroidal anti-inflammatory drugs (NSAIDs) are
considered as etiological factors for this disorder [2].
Antacids, proton pump inhibitors, and histamine H2
receptor antagonists are commonly used drugs [3, 4].
However, beside their therapeutic efficacies, several inci-
dences of relapse, adverse effects and drug interactions
have been shown to be associated with these drugs [5].
Hence, research has been focused on search for new anti-
ulcer molecules from medicinal plants as these molecules
are more relevant to living system and already have definite
biological functions and thus, may have fewer side effects.
As a part of anti-ulcer drug discovery programs of our lab
several Indian medicinal plants including Terminalia che-
bula [6] Xylocarpus granatum [7] and Nyctanthus arbori-
tristis [8] have been reported to possess anti-ulcer activity.
Xylocarpus molluccensis (Lamk) M.Roem. synonymous
Carapa molluccensis (Lamk) belongs to Natural Order
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Meliaceae. It is a mangrove and is commonly known as
pussur and Pitakura in Hindi language. It is a tall tree
ranging up to 10–12 m tall and trunk of 60 cm diameter at
the base, slightly buttressed stem. Bark is red with thick
flacks. Wood red in color, leaflets 7–12 9 3–6 cm ovate,
acute at apex, oblique at the base, flowers 2–3 cm across,
white with red glands inside, stigma cup shaped, fruits
10–15 cm across globose. This species of Xylocarpus is
uncommon and grows in association with Heritiera litter-
alis. It is mainly found in Mahanadi deltaic region and in
Andamans [9]. It has earlier been reported that X. mo-
luccensis have been used in the treatment of cholera and
fever whereas the fruits are aphrodisiac. The bark as well
as pnuematophores of X. moluccensis have been reported
for neuro pharmacological properties [10] whereas its fruits
husk has been reported as bactericidal. The kernels are
used in tonics and in relieving colic. The seeds or peels of
the fruits are utilized to poultice swellings and ash of the
seeds is applied to itch. The fruits are used as a cure for
swellings of the breast and in elephantiasis. The bark
pressings are used to treat fevers including those caused by
malaria. A recent review reveals the various biological
activity, chemical constituents and other properties in the
Xylocarpus genus [11]. The most characteristic of the
genus Xylocarpus are xyloccensins, a class of limonoids.
An earlier report from our laboratory revealed the antihy-
perglycaemic and antidyslipidemic activity in the ethanol
extract of Xylocarpus granatum fruits in the validated
animal models [12]. Keeping in consideration the above
facts, we have selected this plant to determine its potential
effects on gastric ulcer.
2 Results and Discussion
2.1 Effect of xyloccensins X?Y on cold restraint
induced ulcer in rats
Administration of xyloccensins X?Y at graded doses of
10, 20 and 40 mg/kg, p.o. exhibited 25.0, 37.5, and 42.5 %
in CRU model which indicated antiulcer potential of xy-
loccensins X?Y (Fig. 1).
2.2 Effect of Xyloccensins X?Y Alcohol Induced
Ulcer in Rats
Xyloccensins X?Y showed significant anti-ulcer activity
against ethanol induced ulcer showing 67.5 % protection
respectively whereas the reference drug, sucralfate (SUC),
showed 65.67 % protection as depicted in Figs. 2 and 3.
2.3 Effect of Xyloccensins X?Y on Pyloric Ligation
Induced Ulcer in Rats
Anti-ulcer activity of xyloccensins X?Y was also observed
against pyloric ligation induced ulcer model in rats where it
showed protection of 48.0 % whereas reference drug
omeprazole (Omz) showed 65.8 % protection (Fig. 4).
2.4 Effect of xyloccensins X?Y on aspirin induced
ulcer in rats
Xyloccensins X?Y showed potential anti-ulcer activity
(42.5 % protection) in aspirin induced ulcer model, Fig. 5.
Whereas the reference drug omeprazole, showed 58.3 %
protection in comparison to control (Fig. 5).
2.5 Effect of Xyloccensins X?Y on Gastric Secretion
As shown in Table 1, treatment with xyloccensins X?Y at
a dose of 20 mg/kg body weight reduced the free acidity by
8.37 % and total acidity by 10.74 % respectively. Refer-
ence drug omeprazole significantly reduced the free acidity
by 53.62 % and total acidity by 37.43 %. Xyloccensins
X?Y at a dose of 20 mg/kg body weight increased the
mucin secretion by 23.99 % in comparison to control
(Table 1).Whereas the reference drug omprazole exhibited
32.13 % up regualtion of mucin in comparison to control.
Fig. 1 Effect of graded dose of xyloccensins X?Y and reference
drug omeprazole (Omz) on percentage protection of ulcer against cold
restraint induced gastric ulcer models in rats. Data expressed as mean
of % protection of xyloccensins X?Y and reference drugs after ulcer
induction ± S.E.M. Statistical analysis was done by one way
ANOVA followed by Dunnett’s Multiple Comparison Test. *Statis-
tically significant at p \ 0.05 and **p \ 0.01, in comparison to
control. n = 6 in each group
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Our present study demonstrated that xyloccensins X?Y
isolated from Xylocarpus molluccensis possess remarkable
anti-ulcer activity in rats. In India; a large number of herbal
extracts are used in folk medicine to treat various types of
disorders. Xyloccensins X?Y have been studied against
various models of experimentally induced gastric ulcer in
order to evaluate its mechanism of action involved in
prevention of gastric ulcer.
Xyloccensins X?Y exhibited protection in a dose
dependent manner in CRU model. A well-accepted model
is CRU for the induction of gastric ulcers, in which
peripheral sympathetic activation and increased acid
secretion play important roles [13]. In addition, xyloccen-
sins X?Y exerted a protective effect against ethanol-
induced gastric lesions. Ethanol damages the superficial
epithelial layers and inhibits the release of mucosal pros-
taglandins and depresses the gastric defensive mechanisms
[14]. Xyloccensins X?Y appear to augment the gastric
mucosal defense indicating the cytoprotective potentials.
Furthermore, gastric acid is an important factor for the
genesis of ulceration in pyloric-ligated model [15]. In this
model, auto-digestion of mucosa by gastric acid results in
the development of ulcers [16]. Xyloccensins X?Y
reduced free and total acidity in this model, which suggests
its anti-secretory potency.
The cytoprotective ability of xyloccensins X?Y was
evident with increase in mucin content in pyloric ligation
model and protection against ethanol induced ulcer model
in comparison with the reference drugs. To further sub-
stantiate the cytoprotective potency of xyloccensins X?Y,
its effect against NSAIDs induced ulcer model was
explored. Studies suggest that NSAIDs induce ulcers
through their effect on cyclooxygenase enzyme leading to
reduced prostaglandin production and increase in acid
secretion [16]. Our result demonstrated xyloccensins X?Y
significantly increased gastric mucin level and exerted
significant protection in ethanol induced gastric lesions in
rats.
Though different biological activities of Xylocarpus
molluccensis have been reported earlier, anti-ulcer mech-
anism of this plant and its active constituents xyloccensins
X?Y has not been reported till date. Our study is the first
Fig. 2 Effect of xyloccensins X?Y and reference drug sucralfate
(SUC) on percentage protection of ulcer against alcohol induced
gastric ulcer models in rats. Data expressed as mean % protection of
xyloccensins X?Y and reference drugs after ulcer induc-
tion ± S.E.M. Statistical analysis was done by one way ANOVA
followed by Dunnett’s Multiple Comparison Test. *Statistically
significant at p \ 0.05 and **p \ 0.01, in comparison to control.
n = 6 in each group
Fig. 3 Photographs of control, xyloccensins X?Y treated rats and reference drug sucralfate (SUC) treated against alcohol induced gastric ulcer
models in rats
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of its kind to establish the anti-ulcer potential of xyloc-
censins X?Y.
3 Materials and Methods
3.1 Plant Material
Fruits of the Xylocarpus molluccensis mangrove were
collected and identified by Dr. M.N. Srivastava of the
Botany Division, Central Drug Research Institute from
South Andaman Coast in the month of March. Specimen
sample (voucher specimen number 424) has been identified
and preserved in the herbarium of the Botany Division of
the Institute, Lucknow, India. Fruits were shade dried and
crushed.
3.2 Extraction Fractionation and Isolation
of Compounds
Air dried powdered fruits (1.0 kg) were placed in glass
percolator filled with 95 % ethanol 5.0 L and allowed to
stand overnight at room temperature, the percolate was
collected and the process of extraction was repeated four
times. The combined extracts were filtered, concentrated
under reduced pressure below 50 C to minimum volume
of 1.0 L. It was further dried in hot air vacuum oven at
50 C to brown powder (100 g) The brown powder was
suspended in water (70 mL) and fractionated into chloro-
form soluble fraction by extraction with chloroform
(5 9 250 mL) in a separating funnel. The combined
extract was concentrated under reduced pressure below
50 C to get brown viscous mass, which was finally dried
under high vacuum for 2 h to remove the last traces of
solvent (chloroform soluble 25.0 g). The chloroform frac-
tion (20 g) was subjected to silica gel column chromatog-
raphy (60–120 mesh) and the column (1.2 m length and
4 cm in diameter made of glass was used) was eluted with
hexane–ethyl acetate (99:01–0:100) affording 48 fractions
(each fractions of 200 mL volume). Fractions showing
identical TLC pattern were mixed together and grouped
into 6 major groups of fractions. Initial two groups were of
very non polar compounds. Rechromatography of fraction
3 (grouped) over silica gel column using hexane–ethyl
Fig. 4 Effect of xyloccensins X?Y and reference drug omeprazole
(Omz) on percentage protection of ulcer against pyloric ligation
induced gastric ulcer models in rats. Data expressed as mean %
protection of xyloccensins X?Y and reference drugs after ulcer
induction ± S.E.M. Statistical analysis was done by one way
ANOVA followed by Dunnett’s Multiple Comparison Test. *Statis-
tically significant at p \ 0.05 and **p \ 0.01, in comparison to
control. n = 6 in each group
Fig. 5 Effect of xyloccensins X?Y and reference drugs omeprazole
(Omz) on percentage protection of ulcer against aspirin induced
gastric ulcer models in rats. Data expressed as mean % protection of
xyloccensins X?Y and reference drugs after ulcer induc-
tion ± S.E.M. Statistical analysis was done by one way ANOVA
followed by Dunnett’s Multiple Comparison Test. *Statistically
significant at p \ 0.05 and **p \ 0.01, in comparison to control.
n = 6 in each group
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acetate (99:01–98:02) as eluent and 10 fractions were
collected each of 50 mL volume. Fractions showing iden-
tical TLC pattern on silica gel plates were grouped together
and finally by HPLC reverse phase on C18 silica columns
using acetonitrile–water 6:4, v/v at 230 nm using uv-
detector yielded three compounds namely xyloccensin-E
[17] xyloccensin-I [18] and xyloccensins X?Y (Fig. 6).
All of these were characterized using IR, nmr, mass,
derivatization and comparing the data with those given in
literature for these compounds (Xyloccensins E and I).
Xyloccensins X?Y were found to be new structures in the
isomeric forms [19] (Fig. 6). It was a mixture of two new
xyloccensins in the 1:1 ratio on HPLC columns Roy et al.
[19] published complete NMR characterization of these
compounds in the mixture itself.
3.3 Experimental Animals
All experimental protocols were approved by our Institu-
tional Ethical Committee following the guidelines of
CPCSEA (Committee for the Purpose of Control and
Supervision of Experiments on Animals) which complies
with International norms of INSA (Indian National Science
Academy). Sprague–Dawley rats of either sex, weighing
180–200 g were housed in raised bottom mesh cages to
prevent coprophagy and were kept in environmentally
controlled rooms (temperature 25 ± 2 C, humidity
60–80 % and 12 h light and dark cycle).
3.3.1 Materials and Reagents
Omeprazole and other chemicals were procured from
Sigma (St. Louis, MD, USA). Sucralfate was obtained from
Meranani Pharmaceuticals, India, whereas all other
reagents used were of analytical grade.
3.3.2 Treatment Schedule
Graded doses of compounds xyloccensins X?Y (10, 20
and 40 mg/kg p.o.) as well as reference drugs omeprazole
(Omz) (10 mg/kg) and sucralfate (SUC) (500 mg/kg) were
prepared in 1 % carboxymethyl cellulose (CMC) as
Table 1 Effect of and omeprazole (OMZ) on free acidity, total acidity and mucin contents in pyloric ligation model (n = 6 in each group)
Treatment Free acid lequiv/mL Total acid lequiv/mL Mucin lg/mL
Control 70.5 ± 6.20 82.0 ± 5.24 746.00 ± 53.20
Xyloensins X?Y (20 mg/kg) 64.6 ± 2.39 73.19 ± 6.34 981.5 ± 112.33
Omeprazole (10 mg/kg) 32.70 ± 2.65** 51.30 ± 2.09** 1099.08 ± 125.64*
Data expressed as mean of lequiv./mL of xyloccensins X?Y and reference drugs after ulcer induction ± S.E.M. Statistical analysis was done by
one way ANOVA followed by Dunnett’s Multiple Comparison Test. *Statistically significant at p \ 0.05 and **p \ 0.01, in comparison to






















































































Fig. 6 Chemical structures of xyloccensins X?Y
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suspension and administered orally at a dose of 1 ml/200 g
of body weight, 45 min. prior to exposure of ulcerogens.
Animals were fasted for 16 h before ulcerogens exposure
and were divided into three groups, (n = 6).
1. Group I (control) Control group of animals were
treated with vehicle (1 % CMC), 45 min before to
exposure of ulcerogens to the animals.
2. Group II (X ? Y treated) Rats were treated with
xyloccensins X?Y (20 mg/kg, p.o.), 45 min prior to
the induction of gastric ulcer in all ulceration models.
3. Group III (reference drug treated) Rats were treated
with reference drugs, 45 min. prior to the induction of
gastric ulcer in all ulceration models.
3.3.3 Anti-ulcer Activity
3.3.3.1 Cold Restraint Induced Gastric Ulcer
(CRU) Animals were subjected to cold restraint stress
after 45 min of treatment with compounds or reference
drug omeprazole (Omz). Animals in all groups were
immobilized in restraint cage and kept at 4 C in an
environmental chamber [20]. After 2 h, animals were
sacrificed and stomachs were observed and scored under
magnascope for ulcers.
3.3.3.2 Alcohol Induced Gastric Ulcers Model
(AL) Animals for induction of gastric ulcer [21] were
given chilled absolute alcohol (1 mL/200 g, body weight).
Xyloccensins X?Y and sucralfate (SUC) were adminis-
tered 45 min before alcohol treatment. After 1 h of alcohol
administration, animals were sacrificed and stomachs were
cut open along the greater curvature to observe the gastric
lesions appearing as hemorrhagic bands along the mucosal
ridges of the stomach. Lengths of the lesions were mea-
sured using Biovis Image Analyzer software and summated
to give a total lesion score.
3.3.3.3 Aspirin Induced Gastric Ulcer Model (AS) Xy-
loccensins X?Y and reference drug omeprazole (Omz)
were administered 45 min before the treatment of aspirin
(150 mg/kg body weight). Animals were sacrificed after
5 h of aspirin treatment and the stomachs were dissected
out, incised along the lesser curvature and the lesions were
scored [22].
3.3.3.4 Pyloric Ligation Induced Gastric Ulcer Model
(PL) After 45 min of administration of xyloccensins
X?Y and omeprazole (Omz), ulcer was induced by pyloric
ligation under chloralhydrate anesthesia (300 mg/kg, i.p.).
Abdomens were opened and pyloric part of stomach from
each rat was ligated avoiding any damage to the adjacent
blood vessels [23]. Stomachs were replaced carefully and
the animals were allowed to recover with free access to
water. After 4 h, animals were sacrificed and stomachs
were dissected out. Lesions were scored and gastric fluid
was collected and centrifuged at 2000 rpm for 10 min. The
supernatant was collected and used for estimation of gastric
secretion and mucin level.
3.3.4 Gastric Secretion Study in Pyloric Ligation Model
Free and total acidity was measured from the collected
gastric juice by titrating against 0.01 N NaOH, using
phenolphthalein as an indicator and expressed in terms of l
equiv/mL. Mucin level in gastric juice was quantified as
per method reported earlier [24].
3.3.5 Ulcer Scoring
Magnascope (5X magnification) were used for ulcer scor-
ing after induction of ulcer via different ulcerogens. Ulcers
were scored in all models according to method reported
earlier. The severity and intensity of the lesions were
graded as following:
(i) Shedding of epithelium = 10
(ii) Petechial and frank hemorrhages = 20
(iii) One or two ulcers = 30
(iv) More than two ulcers = 40
(v) Perforated ulcers = 50.
3.3.6 Statistical Analysis
All values shown in the figures and tables represent the
mean ± S.E.M. IC50 values with 95 % confidence limits were
estimated using Maximum Likelihood Iterative Procedure [13].
Statistical analysis was performed with Prism version 3.0 soft-
ware using one-way analysis of variance (ANOVA) followed by
Dunnett’s multiple comparison test. p\0.05 was considered to
be statistically significant (p\0.001 = ***, p\0.01 = **,
p\0.05 = *, p[0.05 (ns) = not significant).
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